Weekly Roundup: November 23-27

November 27, 2020
Morgan Petronelli, Associate Editor

ICYMI, some of the content featured this week includes challenges with mohs micrographic surgery in pediatric patients, how a vitamin D deficiency may be linked to acne, three-year dupilumab data for treatment of PsO and PsA, plus more.

In case you missed it, some of this week’s featured content includes stories on how a vitamin D deficiency may be linked to acne, how infant eczema impacts food allergy plans, shingles, a novel fluorescence-advanced videodermatoscopy for characterization of Demodex mites, platelet-rich plasma for anti-aging, how JAKs might predict risk of psoriasis, challenges with mohs micrographic surgery in pediatric patients, three-year dupilumab data for treatment of psoriasis and psoriatic arthritis, plus more.

POLL: Will you be hosting or attending a gathering for Thanksgiving?

The Cutaneous Connection- Episode 12: Antibiotics for Acne

The potential for antibiotic resistance have caused some physicians to be wary of the drug class when prescribing an acne treatment regimen. Christopher Bunick, M.D., Ph.D., clears the air around antibiotic use for acne and discusses his research of narrow-spectrum antibiotics.

The Mainstream Patient: November 23

This week’s edition of The Mainstream Patient features stories on alpha arbutin as a brightening skincare ingredient, a new search tool that pairs skin of color patients with dermatologists, how to handle facial erythema, plus more.

Infant eczema impacts food allergy plan

Infants with eczema may require different approaches to preventing food allergies, including early introduction of peanuts to increase oral exposure to allergens before skin exposure.

Video games and skin ailments

An extensive literature review looks at the dermatoses that are connected to video game play.

Three-year eczema data show sustained safety, efficacy

New study data shows that in adults with atopic dermatitis, dupilumab has performed as expected, with continued efficacy and no new safety signals.

Shingles is more than a rash

Shingles (herpes zoster, or HZ) is more than just a skin manifestation. The condition is also commonly associated with hearing, vision, and balance problems among other symptoms.

Ixekizumab demonstrates long-term efficacy

Ixekizumab demonstrated long-term efficacy in treating psoriasis and psoriatic arthritis across five years, according to data presented by Eli Lilly at the 29th annual European Academy of Dermatology and Venereology (EADV) Congress.

Adjunctive examined for facial erythema

Investigators assessed results combining oxymetazoline and four different lasers in a recent phase 4 study. Results demonstrate improvement from baseline in Clinician Erythema Assessment (CEA) score.

Novel device characterizes mite infestations

Fluorescence-advanced videodermatoscopy (FAV, Adamo Srl) for characterization of Demodex mites suggests that it can be a useful tool in the clinical evaluation and management of patients with Demodex-related skin diseases.

Mohs micrographic presents challenges in kids

While Mohs micrographic surgery is well established as a safe and effective therapeutic modality in adult patients, it is not as commonly used in pediatric populations. There are unique challenges to performing Mohs surgery on pediatric patients, especially with patient cooperation. Multidisciplinary planning may be needed.

Puzzling PRP possibilities and dermatology

The use of platelet-rich plasma (PRP) has grown in popularity over the past few years. Zoe Diana Draelos, M.D., explains the anti-aging benefits of PRP and how it is impacting dermatology.

Study links vitamin D deficiency with acne

Patients with acne should be screened for vitamin D deficiency and insufficiency, according to researchers of a recent study investigating vitamin D's link to acne.

JAKs may predict psoriasis risk

Genetic polymorphisms may increase psoriasis susceptibility, according to a study that found patients who have the G allele in the JAK1 gene have twice the risk of developing psoriasis, and for those with the JAK3 allele, the risk rises nearly 2-fold.